Pharvaris NV
F:9EN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharvaris NV
F:9EN
|
NL |
|
B
|
BuildDirect.com Technologies Inc
XTSX:BILD
|
CA |
|
A
|
Alony Hetz Properties and Investments Ltd
TASE:ALHE
|
IL |
|
S
|
Starbucks Corp
XMUN:SRB
|
US |
|
PTC India Ltd
NSE:PTC
|
IN |
|
O
|
Optimax Holdings Bhd
KLSE:OPTIMAX
|
MY |
|
Guillemot Corporation SA
PAR:GUI
|
FR |
|
Adairs Ltd
ASX:ADH
|
AU |
|
ENDRA Life Sciences Inc
NASDAQ:NDRA
|
US |
|
Cohort PLC
LSE:CHRT
|
UK |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
W
|
Williams-Sonoma Inc
F:WM1
|
US |
|
Avolta AG
F:D2JA
|
CH |
|
M
|
Murata Manufacturing Co Ltd
SWB:MUR1
|
JP |
|
Maxim Power Corp
F:MP9
|
CA |
|
Amplitude Energy Ltd
F:CDP0
|
AU |
|
Obrascon Huarte Lain SA
OTC:OBSJF
|
ES |
|
Aston Martin Lagonda Global Holdings PLC
F:A5S0
|
UK |
|
T
|
Tennant Minerals Ltd
ASX:TMS
|
AU |
|
Conrad Asia Energy Ltd
F:3MD
|
ID |
|
Norsk Hydro ASA
F:NOH1
|
NO |
|
M
|
Macerich Co
F:M6G
|
US |
|
G
|
Grupo Aeroportuario del Centro Norte SAB De CV
SWB:G7AB
|
MX |
Bankruptcy Probability
Pharvaris NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharvaris NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharvaris NV
NASDAQ:PHVS
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
2.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
344.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
268.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharvaris NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharvaris NV has total debt of 481.3k EUR. This includes both short-term (0 EUR) and long-term (481.3k EUR) debt.
You can find a full breakdown on its Balance Sheet.
